Phen2Gene: rapid phenotype-driven gene prioritization for rare diseases. Issue 2 (25th May 2020)

• Record Type: Journal Article
• Authors: Zhao, Mengge; Havrilla, James M; Fang, Li; Chen, Ying; Peng, Jacqueline; Liu, Cong; Wu, Chao; Sarmady, Mahdi; Botas, Pablo; Isla, Julián; Lyon, Gholson J; Weng, Chunhua; Wang, Kai
• Is Part Of: NAR genomics and bioinformatics. Volume 2:Issue 2(2020)
• Publication Date: 2020-05-25
• Subjects: Genomics -- Periodicals; Bioinformatics -- Periodicals; 572.8
• DOI: 10.1093/nargab/lqaa032
• Languages: English
• ISSNs: 2631-9268

Abstract

Abstract: Human Phenotype Ontology (HPO) terms are increasingly used in diagnostic settings to aid in the characterization of patient phenotypes. The HPO annotation database is updated frequently and can provide detailed phenotype knowledge on various human diseases, and many HPO terms are now mapped to candidate causal genes with binary relationships. To further improve the genetic diagnosis of rare diseases, we incorporated these HPO annotations, gene–disease databases and gene–gene databases in a probabilistic model to build a novel HPO-driven gene prioritization tool, Phen2Gene. Phen2Gene accesses a database built upon this information called the HPO2Gene Knowledgebase (H2GKB), which provides weighted and ranked gene lists for every HPO term. Phen2Gene is then able to access the H2GKB for patient-specific lists of HPO terms or PhenoPacket descriptions supported by GA4GH (http://phenopackets.org/ ), calculate a prioritized gene list based on a probabilistic model and output gene–disease relationships with great accuracy. Phen2Gene outperforms existing gene prioritization tools in speed and acts as a real-time phenotype-driven gene prioritization tool to aid the clinical diagnosis of rare undiagnosed diseases. In addition to a command line tool released under the MIT license (https://github.com/WGLab/Phen2Gene ), we also developed a web server and web service (https://phen2gene.wglab.org/ ) for running the tool via web interface or RESTful API queries. Finally, we have curated a large amount of benchmarking data for phenotype-to-gene tools involving 197 patients across 76 scientific articles and 85 patients' de-identified HPO term data from the Children's Hospital of Philadelphia.